 | Targeted delivery by topical application, 2008 - 2011
Funded by: National Health and Medical Research Council |
 | PA Foundation Project Funding for the Therapeutics Research Unit (2008), 2008 - 2008
Funded by: PA Foundation |
 | NHMRC SENIOR PRINCIPAL RESEARCH FELLOWSHIP, 2006 - 2010
Funded by: National Health and Medical Research Council |
 | A phase II randomised controlled trial of atorvastatin therapy in intensive care patients with severe sepsis (NHMRC Project Grant administered by Monash University), 2008 - 2009
Funded by: Monash University |
 | NICM Collaborative Centre for Transitional Preclinical and Clinical Research in Nutraceuticals and Herbal Medicine., 2008 - 2010
Funded by: National Institute of Complementary Medicine |
 | Dermal penetration of metal-based nanotaggants, 2008 - 2009
Funded by: United Stated Department of the Air Force (US Air Force) |
 | Assessment of topically treated non melanoma skin cancers by sequential optical biopsies using multiphoton microscopy, 2008 - 2009
Funded by: Cancer Council Queensland |
 | Antibiotic dosing in the at risk critically ill patient, 2008 - 2010
Funded by: National Health and Medical Research Council |
 | Topical peptide delivery for cosmetic and therapeutic benefits, 2008 - 2011
Funded by: Australian Research Council, OBJ Limited |
 | Improved quantification of spatial and temporal changes in plasma and tissue drug levels and tissue pathology
, 2008 - 2008
Funded by: National Health and Medical Research Council |
 | Relationship between melanosome distribution and skin colour, 2007 - 2010
Funded by: Australian Research Council, University Of Queensland |
 | Block funding grant for Therapeutics Research Unit, 2007 - 2007
Funded by: PA Foundation |
 | Micro-nanoprojection patches for minimally-invasive and targeted delivery of genes and drugs to skin cells: from concept to technology platform, 2007 - 2009
Funded by: Australian Research Council, University Of Queensland |
 | Optimal antibiotic dosing in burns: Fluid dynamics and drug tissue pharmacokinetics, 2006 - 2006
Funded by: Princess Alexandra Hospital Auxiliary |
 | Evaluation of topical delivery of therapeutic compounds by ultrasound and dermal abrasion, 2005 - 2007
Funded by: Pfizer Pty Ltd |
 | Pharmacokinetic Modelling of Various B-lactam Antibiotics in Critically-ill Patients using Microdialysis, 2006 - 2007
Funded by: Australian & New Zealand College of Anaesthetists |
 | Optimal Antibiotic Dosing in Burns: Fluid Dynamics and Drug Tissue Pharmacokinetics, 2005 - 2005
Funded by: Australian & New Zealand College of Anaesthetists |
 | Altered hepatic pharmacokinetics as a consequence of drug- and disease-induced changes in hepatic vascularity, 2006 - 2008
Funded by: National Health and Medical Research Council |
 | Vanomycin dosing in patients with sepsis: Can we do better?, 2005 - 2005
Funded by: Princess Alexandra Hospital Auxiliary |
 | Development of an experimental intensive care facility, 2005 - 2006
Funded by: Princess Alexandra Hospital Auxiliary |
 | Management of burn injury: Fluid dynamics and antibiotic pharmacokinetics, 2005 - 2007
Funded by: National Health and Medical Research Council |
 | Targeted drug delivery by topical application, 2005 - 2007
Funded by: National Health and Medical Research Council |
 | PAHF block funding, 2003 - 2006
Funded by: Princess Alexandra Hospital Auxiliary |
 | Effect Of Liver Pathophysiology On Hepatic Pharmacokinetics, 2003 - 2005
Funded by: National Health and Medical Research Council |
 | Research support for Therapeutics Research Unit, 2003
Funded by: Interderm Pty Ltd |
| Page: | 1 2 3 4 |
| |
| Select all records |
| |